In individuals with obesity, alterations in lipolysis, fatty acid delivery to skeletal muscle, insulin and catecholamine responses, as well as impairments in mitochondrial transport and oxidation, may shift the Fatmax intensity or reduce MFO due to specific metabolic restrictions. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.